Nutex Investments PLC
NUTEX Investments Public Limited Company provides health preserving, health improving, dietary supplement, and cosmetic products in Hungary and internationally. The company was formerly known as HUMET Trade, Research and Development Public Limited Company and changed its name to NUTEX Investments Public Limited Company in February 2011. The company was incorporated in 1996 and is based in Budapes… Read more
Nutex Investments PLC - Asset Resilience Ratio
Nutex Investments PLC (NUTEX) has an Asset Resilience Ratio of 57.37% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2024)
This chart shows how Nutex Investments PLC's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Nutex Investments PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Ft0.00 | 0% |
| Short-term Investments | Ft2.87 Billion | 57.37% |
| Total Liquid Assets | Ft2.87 Billion | 57.37% |
Asset Resilience Insights
- Very High Liquidity: Nutex Investments PLC maintains exceptional liquid asset reserves at 57.37% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Nutex Investments PLC Industry Peers by Asset Resilience Ratio
Compare Nutex Investments PLC's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF |
Drug Manufacturers - Specialty & Generic | -0.02% |
|
Kamada
NASDAQ:KMDA |
Drug Manufacturers - Specialty & Generic | 21.63% |
|
Dongwha Pharm.Co.Ltd
KO:000020 |
Drug Manufacturers - Specialty & Generic | 1.92% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.46% |
|
Yuhan Corp.
KO:000100 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
|
Kotra Industries Bhd
KLSE:0002 |
Drug Manufacturers - Specialty & Generic | 9.82% |
|
Yuyu Pharma Inc
KO:000227 |
Drug Manufacturers - Specialty & Generic | 1.74% |
Annual Asset Resilience Ratio for Nutex Investments PLC (2021–2024)
The table below shows the annual Asset Resilience Ratio data for Nutex Investments PLC.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 57.37% | Ft2.87 Billion | Ft5.00 Billion | +21.16pp |
| 2023-12-31 | 36.21% | Ft1.98 Billion | Ft5.48 Billion | +7.33pp |
| 2022-12-31 | 28.88% | Ft1.53 Billion | Ft5.31 Billion | +20.04pp |
| 2021-12-31 | 8.84% | Ft457.39 Million | Ft5.17 Billion | -- |